Document is current

Any future updates will be listed below

Phase II Study of Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab as a Later-line Therapy for Patients with Metastatic Colorectal Cancer (mCRC): a prospective single-center explorative study

Crossref DOI link: https://doi.org/10.1038/s41416-024-02885-3

Published Online: 2024-10-24

Published Print: 2024-12-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark